Tirzepatide GLP-1 medication may be most effective for weight loss
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia.
Jun 15, 2026
0
11
Clinical pharmacology news
Targeting delivery to the lungs: Inhaled vitamin D could be new strategy
People with chronic lung diseases like chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis tend to have low vitamin D levels, and these low levels are linked to worse respiratory health outcomes. This ...
Jun 15, 2026
0
7
Tirzepatide may change how the body uses energy, trial suggests
Tirzepatide doesn't just help people lose weight; it also activates brown adipose tissue, representing a major milestone in obesity research, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting ...
Jun 15, 2026
0
5
As injectable peptides surge online, researchers warn regulation is falling behind
A new Viewpoint published in JAMA from researchers at the University of Queensland, the University of Toronto and the University of California, San Francisco, is raising concern about a fast-growing but poorly understood ...
Jun 15, 2026
0
5
ENDO: GLP-1 receptor agonists tied to higher hypotension risk in patients on BP meds
Among patients with preexisting hypertension taking antihypertensive medications, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with an increase in hypotensive-related events, according to a study ...
Jun 15, 2026
0
4
Clinical trials suggest GLP-1s may improve fertility in men with obesity
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
5
Behavioral modifications like goal setting could lead to greater weight loss on tirzepatide
One of the largest real-world studies of people taking GLP-1 medications found women, those without pre-existing conditions such as type 2 diabetes and high blood pressure, and behavioral factors such as previously setting ...
Jun 15, 2026
0
3
Study of 5.8 billion medicines dispensed in England exposes stark health inequalities
Scientists have revealed striking inequalities and changing trends in medicines dispensing for more than 52 million people living in England during and after the COVID-19 pandemic.
Jun 15, 2026
0
2
Laxative drug could ease depression-related brain fog, early trial suggests
People with depression who find that it affects their memory or attention span could benefit from an existing licensed drug currently used to treat chronic constipation.
Jun 14, 2026
0
52
Semaglutide linked to lower bone fracture risk
In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...
Jun 14, 2026
0
8
